Search
S-Hydroxycysteine
go.drugbank.com/drugs/DB01915ExperimentalIt targets the proteins subtilisin BPN', glutathione S-transferase A1, glutathione S-transferase p, myelin P2 protein, and complement c3.
Bevacizumab
go.drugbank.com/drugs/DB00112ApprovedInvestigational[A192888,A192939] The same anti-VEGF activity that suppresses tumor angiogenesis also suppresses the pathological choroidal and retinal neovascularization that drives vision loss in retinal disease, giving
Categories: VEGF/VEGFR (Vascular Endothelial Growth Factor / -Receptor) inhibitorsCalcium levulinate
go.drugbank.com/drugs/DB13800ApprovedThe relatively new calcium levulinate is produced from a direct reaction between L- or levulinic acid levulose and calcium hydroxide . The resultant calcium levulinate formulation, when used as a calcium supplement, possesses a high calc...
SGN-15
go.drugbank.com/drugs/DB05818InvestigationalSGN-15 is studied in the treatment of cancer. It combines a monoclonal antibody with the anticancer drug doxorubicin. Monoclonal antibodies are substances that are made in the laboratory and that can locate and bind to cancer cells. Doxo...
Anpocogin
go.drugbank.com/drugs/DB06552InvestigationalRecombinant nematode anticoagulant protein c2 (rNAPc2) is a specific inhibitor of tissue factor (TF)/factor VIIa complex with novel antithrombotic activity.
P2X purinoceptor 3
go.drugbank.com/bio_entities/BE0009818TargetHumansExtracellular ATP-activated non-selective cation channel (PubMed:10440098, PubMed:27626375, PubMed:29674445, PubMed:31232692). Plays particularly important role in sensory neurons where its activation is critical for gustatory, nocicepti...
Synonyms: ATP receptor, Purinergic receptorP2X purinoceptor 2
go.drugbank.com/bio_entities/BE0009820TargetHumansATP-gated nonselective transmembrane cation channel permeable to potassium, sodium and calcium (PubMed:10570044, PubMed:31636190). Activation by extracellular ATP induces a variety of cellular responses, such as excitatory postsynaptic r...
Synonyms: ATP receptor, Purinergic receptorSF1126
go.drugbank.com/drugs/DB05210InvestigationalSF1126 is an integrin-targeted PI3 kinase inhibitor.